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Abstract
Background: To evaluate the long-term surgical outcome(s) in patients who have undergone
canal-wall-down operation with mastoid and epitympanic obliteration using autologous cortical
bone chips, bone pate and meatally-based musculoperiosteal flap technique.
Method: Retrospective evaluation of seventy patients operated during 1986–1991 due to a
cholesteatoma. An otomicroscopy was performed to evaluate the postoperative outer ear canal
configuration with a modified Likert scale (1 – 4). The outer ear canal physical volume was assessed
by tympanometry. The hearing outcome and a patient-filled questionnaire were also analyzed.
Results: The posterior wall results were 1.8 (± 0.9 SD) and the attic region 1.8 (± 0.9 SD) (ns., p
> 0.05). These values show either no cavity formation or minor formation of a cavity, with a good
functional result. The mean volume of the operated ear canal was 1.7 (± 0.5 SD) ml. The volume
of the contralateral ear canal was 1.2 (± 0.3 SD) ml (*** p < 0.0001). A comparison of the current
mean ABG to the preoperative mean ABG and to the ABG at one-year postoperatively, 5-years
postoperatively or 10-years postoperatively showed no statistical significance (p > 0.05).
Conclusion: ABG does not significantly change in the long-term. The configuration of the cavity
tends to change, however, the obliteration material is stable in the long-term and clinically
significant cavitation rarely occurs.
Background
Canal-wall-down (CWD) tympanomastoidectomy is a
well established method in surgery due to cholesteatoma
[1]. It provides a good intraoperative exposure and an easy
postoperative monitoring. The size of the surgical cavity
can be diminished with obliteration to create a small cav-
ity that is self-cleaning and easily maintained [2]. Several
authors have demonstrated the usefulness of mastoid
obliteration technique and considered it a safe method to
diminish a surgical cavity in CWD surgery [3-7]. However,
there are only a few studies that have evaluated the config-
uration of the cavity and the durability of the obliteration
material itself in the long-term [6,8-10].
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sible problems [11]. Both autologous and synthetic mate-
rials have been used for obliteration [3,12-14]. In our
clinic, autologous cortical bone chips and pate, a meatally
based musculoperiosteal flap ("Palva flap"), and tempo-
ral fascia are mainly used. The CWD tympanomastoidec-
tomy with this obliteration method has been well
characterized [15,16].
We have studied the long term condition of ears that
underwent CWD mastoidectomy with mastoid and epit-
ympanic obliteration using autogenous bone chips, bone
pate and a musculoperiosteal flap. All the patients that
participated in the study were followed at least for 15
years. Clinical experience suggests that the configuration
of the cavity changes during the long-term follow-up.
Parts of the cavities tend to enlarge and cavities that are
difficult to treat occur [17]. We have measured the vol-
umes of the reconstructed ear canals, and evaluated the




Between the years 1986 – 1991, a series of 133 CWD tym-
panomastoidectomies, due to a cholesteatoma, were per-
formed. A musculoperiosteal flap ("Palva flap") was used
with autogenous bone for obliteration and reconstruc-
tion, by experienced otosurgeons at the Department of
Otorhinolaryngology, University of Helsinki. The autoge-
nous cortical bone chips (approximate size 0.5 – 1 cm2),
and cortical bone pate were taken from the temporal
bone, above the mastoid. The mastoid cavity and epitym-
panum were filled with these bone chips and bone pate.
The obliterated cavity was lined with a piece of temporal
fascia and with the musculoperiosteal flap. The flap was
not fixed. The ossicular chain was reconstructed either
during the analyzed CWD surgery with obliteration or in
a later tympanoplasty with autologous ossicular bone or
autologous cortical bone. Meatoplasty was not performed
routinely. The ear was packed and at the one week follow-
up, the packing was removed.
All these patients were invited to the study and were sent
an informed consent. Of the 94 patients willing to partic-
ipate, 70 took part in the study. The patient data, operative
details and audiological evaluations were collected retro-
spectively and analyzed.
Ethical consideration
The design of this study was proved by the local ethical
committee at the Department of Otorhinolaryngology,
University of Helsinki. All these patients gave their written
informed consent to participate in the study.
Otological and audiological examination
An otomicroscopy and a tympanometry were performed.
In addition, the diameter of the entrance of the outer ear
canal was measured with the aid of an ear speculum (6
mm, 8 mm, 10 mm or more). The formation of the cavity
in the outer ear canal and in the attic region was evaluated
with a modified Likert scale (1 = no cavity formation; 2 =
minor formation of a cavity, with a good functional result;
3 = moderate cavity formation, crusting; 4 = major cavity
formation, crusting, cholesteatomatic growth in the cav-
ity) by four otosurgeons. Pure-tone audiometry thresh-
olds (0.5, 1, 2 and 4 kHz PTA) via air- (AC) and bone-
conduction (BC) were determined and the air-bone gap
(ABG) was calculated. The patients filled in a question-
naire and the data of the questionnaires were analyzed
with PrismStat (GraphPad Software Inc., San Diego, USA)
(Appendix 1). In the questionnaire the patients were
asked the frequency of mastoid debridements and
whether the ear had been dry or had it discharged since
the surgery. Also problems with the use of hearing aids
were evaluated. The t-test was used for statistical analysis
(* p < 0.05).
Results
Patient population
In our study there was a male preponderance, 48 males
versus 22 females participated. The mean age of the
patients at the operation was 40 (± 13 SD) years (range
from 7 to 66 years) and at the time of evaluation was 59
(± 13 SD) years (median 60 years) with a mean follow-up
period 18 (± 1.5 SD) years (median 18 years).
Twenty patients had been previously (before 1986–1991
period) operated due to a cholesteatoma (Table 1). Of
those patients, three had been operated three times and
one patient operated twice. Nearly all the previous opera-
tions had been CWD operations, without obliteration or
reconstruction of the attic. Of the patients we evaluated
between 1986 and 1991 all were aimed to be single stage
surgeries. During the analyzed CWD surgery, six patients
had a meatoplasty. After the CWD surgery, 21 (30%) had
a second operation to the evaluated operated ear (Table
2). One patient was operated twice and one three times.
Six patients were operated due to a recurrent cholest-
Table 1: Operations to the studied ear prior the evaluated CWD 
surgery
Type of surgery Number of surgeries
CWD operation, without obliteration 19 (27%)
Simple mastoidectomy 4 (6%)
CWU operation 3 (4%)
Atticotomy 1 (1%)
The type and number of ear surgeries to the analyzed ear prior to the 
analyzed operation (20 patients).Page 2 of 7
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our material.
Otomicroscopy and volume of the cavity
In 32 patients we had to use a 6 mm ear speculum. In 29
patients it was possible to use 8 mm ear speculum and
only in four cases a 10 mm speculum or larger was used.
The size and configuration of the ear canal and/or cavity
were estimated. The formation of a cavity in the operated
ear was evaluated with an otomicroscope (modified Likert
scale, 1 – 4). Most of the operated ears showed a good
functional result. The posterior wall of the ear canal and
the attic region were analyzed separately. The posterior
wall results were 1.8 (± 0.9 SD) and the attic region 1.8 (±
0.9 SD) (ns. p > 0.05) (Table 3). One tympanic membrane
perforation was seen. An aerated tympanum was found in
52 patients and an adhesive tympanum was found in 18
patients. The mean volume of the operated ear canal was
1.7 (± 0.5 SD) ml (n = 70). The volume of the contralat-
eral ear canal was 1.2 (± 0.3 SD) ml (n = 59)(*** p <
0.0001).
Audiological data
The mean AC, BC and ABG values (value ± SD) at different
time points are shown in Table 4. A significant difference
could be seen between the current mean AC values com-
pared to all other time points (pre-operative, p = 0.002; 1-
year, p = 0.001; 5-years, p = 0.004; 10-years, 0.004). Also
the current mean BC values were significantly different
compared to all the other time points (pre-operative, p <
0.001; 1-year, p < 0.001; 5-years, p = 0.01; 10-years, p <
0.001). However, no significant differences could be seen
between the current mean ABG and other time points
(pre-operative, p = 0.9; 1-year, p = 0.7; 5-years, p = 0.09;
10-years, 0.6). Twenty patients (29%) had an excellent
(0–10 dB) or a good (11–20 dB) gap closure one-year
after the evaluated surgery. Currently 25 patients (36%)
have an excellent or good gap closure in the operated ear
(Table 5).
Questionnaire
The need for debridement of the cavity was evaluated.
Currently, 35 patients (50%) had no need for debride-
ment of the cavity. The need for debridement diminished
in the long run (Figure 1).
Twenty-nine patients (40%) were hearing aid users.
Twenty-two of these (76%) were using a hearing aid in the
operated side or in both sides. Sixteen of these patients
(73%) were comfortable using the hearing aid in the oper-
ated ear. On the other hand, five patients had recurrent
problems and four patients were unable to wear the aid in
the operated ear. Typical problems which these patients
were encountering: recurrent infection of the cavity due to
hearing aid use (7 patients), fitting problems (5 patients),
poor hearing level (6 patients) or combination of these.
Discussion
A total of 133 patients underwent CWD surgery with com-
plete epitympanic and mastoid obliteration 18 (± 1.5 SD)
years ago at our department. Of these, 94 patients were
willing to participate and 70 (53%) took part in the study.
The data of patients that gave their written informed con-
sent but did not actually participate, were not included.
Dense cortical bone chips, collected from the mastoid
bone, and cortical bone pate were used for the oblitera-
tion of the surgical cavity. A meatally based musculoperi-
osteal flap was raised when CWD surgery was anticipated.
We were especially interested in the stability of the oblit-
eration material that was used. The musculoperiosteal
flap atrophies postoperatively, but it often leaves a
smooth lining for the cavity [15]. Reconstructed canal
walls and reconstructed epitympanic cavities tend to
enlarge postoperatively [2]. Sometimes these pockets are
deep and may cause cholesteatomatic growth in the cav-
ity.
Our results show that the mastoid obliteration with
autogenous cortical bone, mainly cortical bone chips, is
an efficient and long lasting way to diminish the surgical
cavity. Most of the cavities were small and predominantly
trouble free. The meatally based musculoperiostel flap
will provide a smooth surface for the cavity and deep
pockets with cholesteatomatic growth are rare. We
Table 2: Operations to the studied ear after the evaluated CWD 
surgery




Re-radical operation 6 (9%)
The type and number of ear surgeries of patients that had revision 
surgeries to the analyzed ear after the analyzed operation (21 
patients).
Table 3: Posterior wall and attic reconstruction
Mean 1 2 3 4
1.8 ± 0.9 (posterior wall) 28 (40%) 29 (41%) 7 (10%) 5 (7%)
1.8 ± 0.9 (attic) 31 (44%) 25 (36%) 9 (13%) 4 (6%)
The degree of cavitation was analyzed with a modified Likert scale (1 
= no cavity formation; 2 = minor formation of a cavity, with a good 
functional result; 3 = moderate cavity formation, crusting; 4 = major 
cavity formation, crusting, cholesteatomatic growth in the cavity). 
Posterior wall and attic region were analyzed separately. The 
numbers of patients with different degrees of cavitation are shown. 
The mean of cavitation values are shown on the left. (ns., p > 0.05).Page 3 of 7
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bone from the epitympanic area compared to the mastoid
area.
No meatoplasty was routinely done to our patients during
the analyzed CWD surgery with obliteration. However, in
six cases meatoplasty was performed. During the follow-
up, meatoplasty was done to nine patients. Twenty
patients were operated earlier and some of them in other
hospitals. It is possible that some of these patients had
meatoplasty, which was not mentioned in our patient
records. To our knowledge, at least 15 patients (21%) had
a meatoplasty. During the last follow-up visit, it was pos-
sible to do an otomicroscopy to all of the patients and reli-
ably evaluate the ear canal and tympanic membrane.
The acoustic properties of an obliterated cavity are consid-
ered to be better than an open cavity [18-21]. It is possible
that new bone formation facilitated by a periosteal flap in
the CWD cavity may provide acoustic properties similar to
those of the normal ear canal [18,22,23]. Our results with
hearing were acceptable, showing that in CWD surgery,
the tympanoplasty does save the hearing even in the long
run. The differences between the preoperative, 1-year, 5-
year, 10-year and current ABGs were not statistically sig-
nificant. 25 patients (36%) showed good or excellent gap
closure after a mean follow-up period of 18 ± 1.5 years.
This can be considered as a good result.
Twenty-nine patients (40%) were hearing aid users. In
most cases the aid was fitted into the operated ear. Those
patients felt comfortable using the hearing aid in the oper-
ated ear. The benefit of using a hearing aid among our
patients seems to be the same as with elderly unoperated
patients [24,25]. Also the problems our patients encoun-
tered were of same kind as compared to elderly unoper-
ated hearing aid users [24,25].
A 7-year follow-up of the reconstructed ear canals showed
that the ear canal has a tendency to enlarge due to the
atrophy of the musculoperiosteal flap [15,16]. Our results
show that the difference of the volume between the oper-
ated and unoperated ears is significant. However, clini-
cally this difference is still quite unsignificant due to the
fact that most of the cavities were self-cleaning and did
not contain significant retractions.
Epidermoid cells that are not removed at the initial oper-
ation can regrow and cause a residual cholesteatoma [11].
Even beyond 6 years follow-up residual cholesteatomas
are still observed [11]. No residual cholesteatomas were
seen in our material during a mean follow-up period of 18
± 1.5 years. No cholesteatomas were found or operated
that would have been located among the obliteration
material. The autogenous material was always taken
before the actual surgery.
Formation of new retraction pockets to the cavity can
retain keratin and develop into a new disease as a recur-
rent cholesteatoma. Six revision radical operations (9%)
were performed after the initial CWD surgery. These oper-
ations were done due to recurrent cholesteatoma and
dehiscence of the autogenous obliteration material. An
attempt was made to perform the CWD operations with
obliteration as a single stage surgery, but revisions were
Table 4: Mean AC (air conduction), BC (bone conduction) and ABG (air-bone gap) values of the patients during the follow-up
Preoperative Postoperative 1-yr Postoperative 5-yr Postoperative 10-yr Postoperative current
Mean AC 47 ± 5 47 ± 9 45 ± 8 45 ± 7 59 ± 9
Mean BC 21 ± 7 21 ± 8 24 ± 7 20 ± 5 31 ± 9
Mean ABG 27 ± 7 25 ± 6 22 ± 5 25 ± 7 26 ± 7
The preoperative, 1-year postoperatively, 5-years postoperatively, 10-years postoperatively mean AC, BC and ABG values (all 0.5, 1, 2 and 4 kHz 
PTA)(value ± SD).
Table 5: Patients air-bone gaps during the follow-up
Air-bone gap (dB) Preoperative Postoperative 1-yr Postoperative 5-yr Postoperative 10-yr Postoperative current
No. % No. % No. % No. % No. %
0–10 (excellent) 4 6 5 8 5 11 5 15 4 6
11–20 (good) 16 24 20 31 15 41 11 32 21 30
21–30 (fair) 20 29 14 5 10 27 7 21 19 27
> 30 (poor) 28 43 25 39 7 19 11 32 26 37
The preoperative, 1-year postoperatively, 5-years postoperatively, 10-years postoperatively and the current ABG of the operated ear.Page 4 of 7
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rent cholesteatoma (9%).
Conclusion
Currently, over half of our patients do not need regular
debridements. The configuration of the cavity tends to
change in the long-term. However, the obliteration mate-
rial is stable and clinically significant cavitation rarely
occurs.
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Appendix 1
The questionnaire complited by the patients
The Questionnaire
1. How often did/do you visit your surgeon due to prob-
lems related to the operated ear?
a) 1–2 years after the surgery
1 once/year or seldom
2 1–2 times/year
3 3–6 times/year
4 over 6 times/year
b) 5–10 years after the surgery
1 not at all
2 once/year or seldom
3 1–2 times/year
4 3–6 times/year
5 over 6 times/year
c)lately
A histogram showing the need of cavity debridementFigure 1
A histogram showing the need of cavity debridement. On the left side: 1–2 years after the surgery (a = no need for 
debridement, b = once per year or less, c = 1–2 times/year, d = 3–6 times/year, e = over 6 times/year); on the middle set of 
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2 once per year or seldom
3 1–2 times/year
4 3–6 times/year
5 more than 6 times/year
2. Has the ear discharged after the surgery?
1 never
2 there have been only a few periods of discharge
3 the ear is discharging frequently
4 it is discharging continuously
3. Have you had a revision operation? Yes no
When? Where?
4. Are you using a hearing aid? Yes no
5. I use hearing aid(s):
1 in the operated ear
2 in the contralateral ear
3 in both ears




4 due to problems I do not wear it in the operated ear
7. What kinds of problems did/do occur if you are using a
hearing aid?
1 ear starts to discharge
2 insertion problems with the ear piece
3 the hearing level of the ear is too poor to wear an aid
4 others? What kinds of problems?




4 over 10 years
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